His health principles Canada announced today that they have approved its use vaccine of Pfizer/BioNTech against coronavirus for children aged 5 to 11 years.
“After a full independent scientific examination, the Ministry of (Health) found that the benefits of this vaccine for children aged 5 to 11 years prevail of the risks “, the Ministry of Health states in a statement.
The dosage of the vaccine for children aged 5 to 11 years decreased to 10 micrograms per injection, that is, it is three times lower than the standard dose, broadcasts by ΑΠΕ ΜΠΕ. The doses should also be given “within three weeks,” said the Canadian Department of Health, which has not yet announced a date for the start of the vaccination campaign.
No serious side effects were reported
During the clinical trial, the immune response of children aged 5 to 11 years was comparable to that of young people aged 16 to 25 years. The vaccine was effective against 90,7% for the prevention of Covid-19 in children aged 5 to 11 years and no serious side effects have been recorded, the ministry further clarifies.
The Pfizer / BioNTech alliance applied for its vaccine on November 18, based on test data conducted in 2,268 children of the age group.
Gradual expansion of vaccination campaigns in children under 12
Elsewhere in the world, a small number of countries, including Israel, have so far approved the Pfizer / BioNTech vaccine for children, points out the RES EIA.
THE China, τα United Arab Emirates, the Cambodia and the Colombia They also started vaccinating children under the age of 12 but with Chinese vaccines.

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.